CSIMarket
 
Casi Pharmaceuticals inc   (CASI)
Other Ticker:  
 
 

Casi Pharmaceuticals Inc Balance Sheet Annual

CASI


Select the Financial Report:   Period:   Fiscal Year:




CASI Balance Sheets
(Annual, GAAP in millions $)

(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
(Dec 31 2020)
2020
(Dec 31 2019)
2019
ASSETS
Cash & cash equivalent 17.08 47.11 38.70 57.06 53.62
Cash, Cash Eqvivalents Other - - - - -
Short-term Investments, Total 12.01 2.76 9.87 9.31 0.63
Cash & Short-term Investments 29.09 49.88 48.57 66.37 54.25
Accounts receivable 9.55 12.97 9.80 4.65 1.29
Other Receivables 0.59 - - - -
Notes Receivable, Current - - - - -
Term Deposit Current - 1.46 - - -
Investment Equity Securities Fair Value 1.68 - - - -
Term Deposit Noncurrent - 3.07 - - -
Inventories 15.88 6.14 1.91 1.36 4.54
Other Current Assets 1.68 1.46 - - -
Prepaid Expense And Other Assets Current 2.56 2.98 1.69 1.65 1.42
Total Current Assets 59.34 73.42 61.97 74.03 61.50
Equipment/Property/Plant Net 9.24 11.83 12.71 2.06 0.99
Goodwill net - - - - -
Intangible Assets 1.84 1.06 12.20 13.21 16.90
Long-term investments 1.69 4.40 40.13 29.44 14.04
Accounts Receivable, Net, Noncurrent - - - - -
Financial Instruments - - - - -
Tax Assets, Noncurrent - - - - -
Other Assets, Noncurrent 3.00 6.00 4.00 1.00 9.21
Deferred, Prepaid and Other Assets, Noncurrent - - - - -
Discontinued operations, Noncurrent - - - - -
Operating Lease Right Of Use Asset 2.39 1.40 9.11 8.70 -
Total Assets 75.27 96.23 138.30 127.73 102.63
LIABILITIES
Accounts Payable, Current AC 4.44 3.29 4.79 3.67 5.11
Accrued Liabilities, Current AC - - - - 2.83
Financial Instruments - - - - -
Short-term Debt DE1 - - - 0.83 -
Other Liabilities, Current 12.29 11.82 8.40 3.48 -
Taxes Payable, Current, Total - 1.90 - - -
Deferred Liability and Revenue - - - - -
Discontinued Operation, Liabilities, Current - - - - -
Deferred Income - - 2.83 2.35 -
Total Current Liabilities 16.73 17.01 13.19 7.98 7.95
Long-term debt 18.90 - - - -
Capital Lease and Other - - - - -
Long-term Debt Convertible - - - - -
Total Long-term Debt 18.90 - - - -
Derivative Liability, Noncurrent DE - - - - -
Employee Benefit Plans, Noncurrent - - - - -
Deferred credits, Noncurrent - - - - -
Accrued Income Taxes, Noncurrent - - - - -
Discontinued Operation, Liabilities, Noncurrent - - - - -
Other liabilities, Noncurrent 15.48 12.30 17.15 16.19 1.02
Total Liabilities 51.10 29.30 30.34 24.16 8.97
SHAREHOLDER'S EQUITY
Redeemable Noncontrolling Interest Equity Redemption Value - 22.36 - - -
- - 23.46 22.03 20.67
Common Stock Value 0.00 0.00 1.40 1.24 0.98
Treasury Stock Value -9.60 -9.33 -8.03 -8.03 -8.03
Additional Paid In Capital Common Stock 695.79 691.77 694.83 658.25 606.69
Retained Earnings / Accumulated Deficit -660.82 -637.16 -605.64 -570.50 -523.90
Other Equity 1.40 -14.32 -20.80 -20.53 -23.01
Noncontrolling interests & other - - - - -
Total Stockholder's Equity 24.17 44.57 84.50 81.54 73.00
Liabilities & Stockholder's Equity 75.27 96.23 138.30 127.73 102.63






Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com